Jushi Holdings (JUSHF) Gross Profit (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Gross Profit came in at $29.9 million in Q1 2026, up 15.91% year-on-year from $25.8 million in Q1 2025, and up 4.41% on a QoQ basis from $28.6 million in Q4 2025.
Jushi Holdings (JUSHF) Gross Profit (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Gross Profit data on file, last reported at $29.9 million in Q1 2026.
- On a quarterly basis, Gross Profit rose 15.91% year-over-year to $29.9 million in Q1 2026; TTM through Mar 2026 was $118.1 million, a 5.67% increase from a year earlier, with the FY2025 full-year figure at $114.0 million, down 3.66% from the prior year.
- Gross Profit for Q1 2026 stood at $29.9 million, up from $28.6 million in the prior quarter.
- Over the last five years, Gross Profit for JUSHF reached as high as $32.6 million in Q2 2024 and fell as low as $19.1 million in Q1 2022.
- Historically, Gross Profit has averaged $27.9 million across 5 years, with a median of $28.5 million in 2023.
- Across the five-year window, Gross Profit jumped 56.66% in 2023 and slipped 20.28% in 2025, its largest moves.
- Year by year, Gross Profit stood at $22.0 million in 2022, then climbed by 23.97% to $27.2 million in 2023, then dropped by 6.65% to $25.4 million in 2024, then climbed by 12.62% to $28.6 million in 2025, then advanced by 4.41% to $29.9 million in 2026.
- Per Business Quant data, the three most recent Gross Profit figures were $29.9 million in Q1 2026, $28.6 million in Q4 2025, and $30.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.88 Mn |
| Mar 31, 2026 | 29.88 Mn |
| Dec 31, 2025 | 28.61 Mn |
| Dec 31, 2025 | 28.61 Mn |
| Sep 30, 2025 | 30.66 Mn |
| Sep 30, 2025 | 30.66 Mn |
| Jun 30, 2025 | 28.92 Mn |
| Jun 30, 2025 | 28.92 Mn |
| Mar 31, 2025 | 25.78 Mn |
| Mar 31, 2025 | 25.78 Mn |
| Dec 31, 2024 | 25.41 Mn |
| Dec 31, 2024 | 25.41 Mn |
| Sep 30, 2024 | 28.00 Mn |
| Sep 30, 2024 | 28.00 Mn |
| Jun 30, 2024 | 32.57 Mn |
| Jun 30, 2024 | 32.57 Mn |
| Mar 31, 2024 | 32.33 Mn |
| Mar 31, 2024 | 32.33 Mn |
| Dec 31, 2023 | 27.22 Mn |
| Dec 31, 2023 | 27.22 Mn |